Technology News and Research

RSS

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems

31 Aug 2004

Patent issued for novel method to chill body tissues and organs without forming ice crystals

Body tissues such as blood vessels, cartilage and skin - even whole organs such as kidneys, livers and hearts - could become more widely available for transplants as a result of a patent issued recently to Organ Recovery Systems of Chicago for a method to chill body tissues and organs well below freezing without forming ice crystals.

30 Aug 2004

Study suggests intramyocardial injection of cells from bone marrow might be an alternative for heart transplantation

Cardiovascular disease remains the leading cause of morbidity and mortality around the world and patients with end-stage ischemic heart failure carry the highest morbid-mortality rate.

30 Aug 2004

Cinical trial to evaluate breakthrough breast cancer treatment

Virginia Commonwealth University’s Massey Cancer Center will host 20 medical experts from around the United States on Sept. 9 to prepare for a 3,000-patient phase III clinical trial that will evaluate a breakthrough breast cancer treatment.

30 Aug 2004

High tech implants to aid facial reconstruction

Loughborough University researchers have been awarded more than £200,000 to develop state-of-the-art tailor made implants for people requiring facial reconstructive surgery.

27 Aug 2004

Attention deficit/hyperactivity disorder high among Chernobyl children

In an extensive study of children exposed to varying levels of fallout from the 1986 Chernobyl Nuclear Power Plant accident, Israeli researchers have found that Attention Deficit/Hyperactivity Disorder (ADHD) scores are higher among those who were in-utero at the time of the accident -- regardless of their actual level of radiation exposure.

26 Aug 2004

Study of new gene and cell therapy to better understand how genetically-engineered cells can help pace the heart

Guidant Corporation, Columbia University and Stony Brook University will collaborate to study a new gene and cell therapy that may ultimately provide better understanding of how genetically-engineered cells can help pace the heart.

26 Aug 2004

Artificial heart can keep patients awaiting heart transplant alive

The results of the nine-year study of the CardioWest Total Artificial Heart have concluded that the device prevents death in critically ill patients suffering from irreversible failure of both sides of the heart who are candidates for heart transplantation.

26 Aug 2004

Early cholesterol-lowering drug therapy reduces artery-clogging plaque

Early cholesterol-lowering drug therapy after hospitalization for acute coronary syndrome appears to reduce artery-clogging plaque, according to a study reported in Circulation: Journal of the American Heart Association.

25 Aug 2004

Australian research giant begins trial of avian influenza vaccine

The trial vaccine utilises Imugene Limited's platform adenoviral vector technology to deliver the necessary genetic material to stimulate the birds' immune responses.

25 Aug 2004

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Virginia Commonwealth University researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients and in those with cirrhosis, which may help scientists predict a person’s risk of developing primary liver cancer.

25 Aug 2004

Novel method for studying ancient life forms

Geobiologists are announcing today their first major success in using a novel method of "growing" bacteria-infested rocks in order to study early life forms.

23 Aug 2004

Future for telemedicine is a very bright one

The European telemedicine markets are at a critical growth phase where vendors need to capitalise on growing opportunities and gain the early-mover advantage over competitors.

23 Aug 2004

Peginterferon and Ribavirin combination promising for those with HIV and HCV

Since the introduction of highly active combination drug therapy for HIV, liver failure attributable to infection with the hepatitis C virus (HCV) has become a leading cause of death among those infected with the virus that causes AIDS.

22 Aug 2004

Enzyme activation key to body clock

Feel like time is repeating itself and won’t move on? It could be your internal clock is backpedaling because your PKG-II is out of whack.

20 Aug 2004

Scientists have developed the first mouse model Werner’s syndrome

Scientists have developed the first mouse model of a rare disease in which people age rapidly and start developing cancers and other diseases associated with the elderly when they are only about 30 years old.

20 Aug 2004

Five-in-one vaccine is an important step forward in the UK's vaccination programme

The new five-in-one vaccine is an important step forward in the United Kingdom's vaccination programme, say child health experts in this week's BMJ.

20 Aug 2004

Nucleic acid-amplification testing has improved the safety of the nation's blood supply

State-of-the-art testing systems to screen donated blood have improved the safety of the nation's blood supply by preventing the transmission of potentially deadly viruses, according to a new study funded by the National Heart, Lung, and Blood Institute.

18 Aug 2004

Majority of LASIK recipients are happy with the results

The majority of the million plus people having LASIK each year to correct their vision are happy with the results, according to a 15-year literature review that indicates most reasons for discontent could be resolved with more patient education before surgery.

18 Aug 2004

More tumour cells in the blood leads to quicker deterioration in women with breast cancer

A new study of women with advanced breast cancer who have more tumor cells circulating in their blood deterioate and die quicker than women with fewer of these cells, according to the researchers from the University of Michigan Comprehensive Cancer Center and other cancer centers throughout the country.

18 Aug 2004

Technology News and Research

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

Patent issued for novel method to chill body tissues and organs without forming ice crystals

Study suggests intramyocardial injection of cells from bone marrow might be an alternative for heart transplantation

Cinical trial to evaluate breakthrough breast cancer treatment

High tech implants to aid facial reconstruction

Attention deficit/hyperactivity disorder high among Chernobyl children

Study of new gene and cell therapy to better understand how genetically-engineered cells can help pace the heart

Artificial heart can keep patients awaiting heart transplant alive

Early cholesterol-lowering drug therapy reduces artery-clogging plaque

Australian research giant begins trial of avian influenza vaccine

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Novel method for studying ancient life forms

Future for telemedicine is a very bright one

Peginterferon and Ribavirin combination promising for those with HIV and HCV

Enzyme activation key to body clock

Scientists have developed the first mouse model Werner’s syndrome

Five-in-one vaccine is an important step forward in the UK's vaccination programme

Nucleic acid-amplification testing has improved the safety of the nation's blood supply

Majority of LASIK recipients are happy with the results

More tumour cells in the blood leads to quicker deterioration in women with breast cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News